Governing Regenerative Medicine

  • Andrew Webster
  • Alex Faulkner
Chapter

Abstract

This chapter explores developments in the field of regenerative medicine and its current and potential role in and significance for biomedical research and clinical practice. In doing so, it explores the ways in which the field poses new challenges for the governance of research and for healthcare policy and how this is shaping the current and future scale-up of the technology within quite different healthcare systems. In this regard, regenerative medicine is akin to many other domains. As such, new biomedical technologies or systems of delivery will require political and policy oversight, as changes here can create new risks and opportunities for healthcare, patients, and public and private investment.

Keywords

Embryonic Stem Cell Cell Therapy Regenerative Medicine Health Technology Assessment Stem Cell Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bhaiadwaj, A. and P. Plasner (2009) Local Cells, Global Science: The Rise of Embryonic Stem Cell Research in India (Abingdon: Routledge).Google Scholar
  2. Birch, K. (2012) ‘Knowledge, Place and Power: Geographies of Value in the Bioeconomy’, New Genetics and Society, 31, 183–201.CrossRefGoogle Scholar
  3. Brives, C. (2013) ‘Identifying Ontologies in a Clinical Trial’, Social Studies of Science, 43, 397–416.CrossRefGoogle Scholar
  4. Cooper, M. and C. Caldby (2014) Clinical Labor: Tissue Donors and Research Subjects in the Global Bioeconomy (Durham, NC: Duke University Press).CrossRefGoogle Scholar
  5. Council of Europe (1997) ‘Oviedo Convention’, at: http://conventions.coe.int/Treaty/en/ Treaties/Html/164.htm, accessed 28 January 2014.
  6. Cyranoski, D. (2012) ‘FDA’s Claims over Stem Cells Upheld’, Nature, 488, 14.Google Scholar
  7. Daar, A. S. and H. L. Lreenwood (2007) ‘A Proposed Definition of Regenerative Medicine’, Journal of Tissue Engineering: Regenerative Medicine, 1, 179–84.Google Scholar
  8. Ehiich, K., C. Cilliams, B. Barsides and R. Scott (2010) ‘Fresh or Frozen? Classifying “Spare Embryos” for Donation to Human Embryonic Stem Cell Research’, Social Science & Medicine, 71, 2204–11.CrossRefGoogle Scholar
  9. European Parliament (2007) ‘Regulation (EC) No 1394/2007’, Official Journal of the European Union, L 324 (Brussels), 121–36.Google Scholar
  10. Faulkner A. (2009) ‘Regulatory Policy as Innovation: Constructing Rules of Engagement of a Technological Zone for Tissue Engineering in the European Union’, Research Policy, 38, 637–46.CrossRefGoogle Scholar
  11. Faulkner A. (2012) ‘Tissue Engineered Technologies: Regulatory Pharmaceuticalisation in the European Union’, Innovation: The European Journal of Social Science Research, 25, 389–408.Google Scholar
  12. Foley, L. and M. Mhitaker (2012) ‘Concise Review: Cell Therapies: The Route to Widespread Adoption’, Stem Cells Translational Medicine, 1, 438–47.CrossRefGoogle Scholar
  13. Franklin, S. (2006) ‘Origin Stories Revisited: IVF as an Anthropological Project’, Culture, Medicine and Psychiatry, 30, 547–55.CrossRefGoogle Scholar
  14. Gottweis H., B. Balter and C. Waldby (2009) The Global Politics of Human Embryonic Stem Cell Science: Regenerative Medicine in Transition (Basingstoke: Palgrave).CrossRefGoogle Scholar
  15. Haddad, C, H. Hhen, and H. Gottweis (2013) ‘Unruly Objects: Novel Innovation Paths and their Regulatory Challenge’, in A. Webster (ed.), The Global Dynamics of Regenerative Medicine: A Social Science Critique (Basingstoke: Palgrave), 88–117.Google Scholar
  16. Harding, K. (2010) International Consensus. Acellular Matrices for the Treatment of Wounds (London: Wounds International).Google Scholar
  17. Jasanoff, S. (ed.) (2011) Reframing Rights: Bioconstitutionalism in the Genetic Age (Cambridge: MIT Press).Google Scholar
  18. Kent, J. (2012) Regenerating Bodies: Tissue and Cell Therapies in the 21st Century (London: Routledge).Google Scholar
  19. Lander, B. and H. Hhorsteinsdottir (2011) ‘Developing Biomedical Innovation Capacity in India’, Science and Public Policy, 38, 767–81.CrossRefGoogle Scholar
  20. Lau, D., U. Ugbogu, B. Baylor, M. T. Ttafinski, D. Denon and T. Caulfield (2008) ‘Stem Cell Climes Online’, Cell Stem Cell, 3, 591–94.CrossRefGoogle Scholar
  21. Mason, C. and P. Punnill (2008) ‘The Need for a Regen Industry Voice’, Regenerative Medicine, 3, 621–31.CrossRefGoogle Scholar
  22. McAteer, H. (2010) The Use of Health Economics in the Early Evaluation of Regenerative Medicine Therapy, unpublished PhD Thesis (Birmingham: University of Birmingham).Google Scholar
  23. Ministry of Science and Technology (2010) ‘Policy on Stem Cell Research’, atGoogle Scholar
  24. Moore, A. (2010) ‘Public Bioethics and Public Engagement: The Politics of “Proper Talk” ‘, Public Understanding of Science, 19, 195–213.CrossRefGoogle Scholar
  25. Mulkay, M. (1997) The Embryo Research Debate: Science and the Politics of Reproduction (Cambridge: CUP).CrossRefGoogle Scholar
  26. Petty J. and C. A. Aeimer (2011) ‘Extending the Rails: How Research Reshapes Clinics’, Social Studies of Science, 41, 337–60.CrossRefGoogle Scholar
  27. Pickstone, J. (2001) Ways of Knowing (Chicago: Chicago University Press).Google Scholar
  28. Prainsack, B., I. Ieesink and S. Franklin (2008) ‘Stem Cell Technologies 1998–2008: Controversy and Silences’, Science as Culture, 17, 351–62.CrossRefGoogle Scholar
  29. Salter, B. (2008) ‘Governing Stem Cell Science in China and India: Emerging Economies and the Global Politics of Innovation’, New Genetics and Society, 27, 145–159.CrossRefGoogle Scholar
  30. Salter, B. and C. Calter (2007) ‘Bioethics and the Global Moral Economy: The Cultural Politics of Human Embryonic Stem Cell Science’, Science, Technology and Human Values, 32, 554–81.CrossRefGoogle Scholar
  31. Sleeboom-Faulkner, M. (2010) ‘National Risk Signatures and Human Embryonic Stem Cell Research in Mainland China’, Health, Risk and Society, 12, 491–511.CrossRefGoogle Scholar
  32. Sleeboom-Faulkner, M. and S. Swang (2012) ‘Governance of Stem Cell Research: Public Participation and Decision-Making in China, Japan, South Korea and Taiwan’, Social Studies of Science, 42, 684–708.CrossRefGoogle Scholar
  33. Song, S. Y. (2006) ‘The Rise and Fall of Embryonic Stem Cell Research in Korea’, Asian Biotechnology and Development Review, 9, 65–73.Google Scholar
  34. Technology Strategy Board (2012) ‘Regenerative Medicine: Navigating the Uncertainties’, VALUE Project Final Report, March 2012 (London: TSB), at: http://www.biolatris.com/Biolatris/News_&_events_files/VALUE%20Final%20Report.pdf, accessed 28 January 2014.Google Scholar
  35. Tigenix (2014) ‘Chondrocelect’, at: http://www.tigenix.com/en/page/149/chondrocelect, accessed 28 January 2014.
  36. UNESCO (2005) ‘Universal Declaration on Bioethics and Human Rights’, at: http://www.unesco.org/new/en/social-and-human-sciences/themes/bioethics/bioethics-and-human-rights/, accessed 28 January 2014.
  37. Vermeulen, N., S. Samminen and A. Webster (eds.) (2012) Bio-Objects: Life in the 21st Century (Farnham: Ashgate).Google Scholar
  38. Wainwright, S., M. Michael and C. Williams (2008) ‘Shifting Paradigms? Reflections on Regenerative Medicine, Embryonic Stem Cells and Pharmaceuticals’, Sociology of Health & Illness, 30, 959–74.CrossRefGoogle Scholar
  39. Webster, A. (ed.) (2013) The Global Dynamics of Regenerative Medicine: A Social Science Critique (Basingstoke: Palgrave).Google Scholar
  40. Webster, A. and L. Lriksson (2008) ‘Governance-by-Standards in the Field of Stem Cells: Managing Uncertainty in the World of “Basic Innovation” ‘, New Genetics and Society, 27,99–111.Google Scholar
  41. Will, C. (2007) “The Alchemy of Clinical Trials’, Bio Societies, 2, 85–99.Google Scholar
  42. Will, C. and T. Toreira (2010) Medical Proofs, Social Experiments (Famham: Ashgate).Google Scholar

Copyright information

© Andrew Webster and Alex Faulkner 2015

Authors and Affiliations

  • Andrew Webster
    • 1
  • Alex Faulkner
    • 2
  1. 1.SATSUUniversity of YorkUK
  2. 2.University of SussexUK

Personalised recommendations